Alpha Tau announces October investor conferences for Alpha Tau Medical stock

Published on 10/19/2026 at 03:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Management set October 6 and October 15 meetings on October 5, 2026. Analysts set a USD 15.40 average target for Alpha Tau Medical stock.

Investor calendar and valuation

Alpha Tau announced October conference dates on October 5, 2026, including an October 15 presentation.
Barclays raised its target from USD 17.00 to USD 30.00 on September 3, 2026.
Alpha Tau Medical stock closed at USD 12.29 on October 16, 2026, on Nasdaq.
Market capitalization stood at USD 1.1 billion as of October 16, 2026.

DRTS, IL0011839383, Illustration mit AI erstellt.

Alpha Tau Medical Ltd (IL0011839383) announced on October 5, 2026, that management would attend investor conferences on October 6 and October 15. The release identified Alpha DaRT as the company technology for localized alpha-radiation treatment of solid tumors, according to Yahoo Finance.

October conference dates

The October 6 meeting was a Barclays Biotech 1x1 event in New York. The October 15 presentation was scheduled for the Investment Generation Conference in Rishon Letzion, Israel, with a 12:30 p.m. to 1:00 p.m. local time slot, according to Yahoo Finance.

What do the targets imply?

Analyst expectations remain broad. MarketBeat reported that Barclays raised its price target from USD 17.00 to USD 30.00 on September 3, 2026, while the average target was USD 15.40. The same report said Alpha Tau posted adjusted earnings per share of minus USD 0.50 for the quarter reported on August 10, 2026, compared with a consensus estimate of minus USD 0.14.

Three dated company milestones

On July 21, 2026, Alpha Tau reported a 100.00 percent objective response rate and 18.20-month median overall survival in a head and neck cancer study, according to Quantellect. On August 10, 2026, the company reported the quarterly earnings-per-share figure cited above. On October 5, 2026, it announced the two October investor appearances. The next substantiated reporting date is November 19, 2026, according to Quantellect.

Stock valuation and next date

Alpha Tau Medical closed at USD 12.29 on Nasdaq on October 16, 2026, while its 52-week range was USD 3.47 to USD 15.50 as of October 17, 2026. Market capitalization was USD 1.1 billion as of October 16, 2026. The combination of a November reporting date and a USD 30.00 analyst target leaves clinical data and execution as the main numerical reference points for the stock.